Human immunodeficiency virus (HIV) is a chronic infection that can lead to acquired immunodeficiency syndrome (AIDS) if untreated.
As HIV treatments improve and patients live longer, more people with HIV are developing cardiovascular diseases, including pulmonary arterial hypertension (PAH). Scientists continue to study the connection between these two diseases. Scientists believe that approximately 0.5 percent (or one out of every 200) of people with HIV develop PAH. HIV-positive individuals have roughly 2,500 times the risk of developing PAH than those without HIV.
Shortness of breath is the most common symptom of PAH. Other symptoms include increased fatigue, swelling of the ankles, legs or abdomen, chest discomfort or pain, and lightheadedness and fainting.
Download the Pulmonary Hypertension Association (PHA)’s free patient brochure to learn more about PH risks and treatment options.